FeesSafety
Pluang+

Harmony Biosciences appoints Peter Anastasiou as new CEO starting January 2027, with current CEO retiring.

Company Fundamentals
12 Oct 2026, 18:00 WIB
Na
View Source
Bullish
Harmony Biosciences appoints Peter Anastasiou as new CEO starting January 2027, with current CEO retiring.

Harmony Biosciences announced that Peter Anastasiou will become President and CEO effective January 1, 2027, succeeding Jeffrey M. Dayno, who will retire at the end of 2026. Dayno will remain as a non-executive advisor through 2027 to support the company's growth. The company reaffirmed its 2026 revenue guidance of $1.0 to $1.04 billion for WAKIX and plans to report clinical data for its BP-205 drug in Q4 2026. This leadership change aligns with Harmony's strategic focus on expanding its CNS pipeline, protecting WAKIX exclusivity, and pursuing growth opportunities.

Harmony Biosciences CEO transition news offers context for health sector investors. For readers following health stocks, here is Pluang's market snapshot as of Oct 12, 2026 17:11 WIB: Out of 128 priced US health stocks, 58 rose and 42 fell. Notable movers include ROIV at USD 34.70 down 2.09%, HRTX at USD 0.41 up 2.07%, and ABEO at USD 4.84 down 2.02%. Typical hold times vary from 3 to 36 days on Pluang.

More News

Alphabet and Meta Platforms show strong growth but face distinct risks and valuation differences for 2027.

Alphabet and Meta Platforms show strong growth but face distinct risks and valuation differences for 2027.

Alphabet and Meta Platforms both demonstrate robust revenue growth driven by digital advertising and AI integration, with Alphabet focusing on search and cloud services, and Meta on social media engagement. Alphabet reported $471.1 billion revenue an...

Market News
Bullish
18 minutes ago
Mastercard offers steady growth and stability over Coinbase's volatile crypto exposure for 2027 investments.

Mastercard offers steady growth and stability over Coinbase's volatile crypto exposure for 2027 investments.

Coinbase Global and Mastercard represent two paths in finance: crypto infrastructure versus traditional payments. Coinbase's revenue is tied to volatile crypto trading, showing a 26.6% revenue decline and a net loss of $701.6 million in the past year...

Market News
Neutral
31 minutes ago
Dec 9 key for markets: Fed rate decision, Broadcom earnings, Micron buybacks set to impact stocks.

Dec 9 key for markets: Fed rate decision, Broadcom earnings, Micron buybacks set to impact stocks.

On December 9, three major events will influence the stock market: the Federal Open Market Committee (FOMC) is expected to raise interest rates, Broadcom will report its earnings with a focus on AI semiconductor revenue, and Micron will begin a large...

Market News
Neutral
41 minutes ago
Rising rates challenge Realty Income but its strong dividend and diversification offer resilience.

Rising rates challenge Realty Income but its strong dividend and diversification offer resilience.

Realty Income, a large net-lease REIT with over 15,500 properties, faces headwinds from rising interest rates which increase borrowing costs and pressure profits. However, the company has a strong track record of increasing dividends for 32 years and...

Market News
Bullish
56 minutes ago
DICK'S Sporting Goods favored over Coupang for 2027 due to profitability and valuation despite Coupang's growth.

DICK'S Sporting Goods favored over Coupang for 2027 due to profitability and valuation despite Coupang's growth.

Coupang leads South Korea's e-commerce with strong logistics but faces losses and regulatory challenges, including a major data breach. DICK'S Sporting Goods, expanding through Foot Locker acquisition, shows strong profitability, a solid dividend, an...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App